Sarah Diab

Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3<i>H</i>)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation

Sarah Diab, Theodosia Teo, Malika Kumarasiri et al. · ChemMedChem · 2014 · 81 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Discovery of (<i>E</i>)-3-((Styrylsulfonyl)methyl)pyridine and (<i>E</i>)-2-((Styrylsulfonyl)methyl)pyridine Derivatives as Anticancer Agents: Synthesis, Structure–Activity Relationships, and Biological Activities

Tiangong Lu, Aik Wye Goh, Mingfeng Yu et al. · Journal of Medicinal Chemistry · 2014 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation

Mingfeng Yu, Peng Li, Sunita K. C. Basnet et al. · European Journal of Medicinal Chemistry · 2015 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Nutritional status and quality of life in diabetic patients on hemodialysis: a cross-sectional study from Palestine

Eba’a Hafi, Ro’ya Soradi, Sarah Diab et al. · Journal of Health Population and Nutrition · 2021 · 30 citations · Full text

Medicine, Nephrology, Nutrition +17

A phase I study of R547, a novel, selective inhibitor of cell cycle and transcriptional cyclin dependent kinases (CDKs)

Sarah Diab, S. Gail Eckhardt, Antoinette R. Tan et al. · Journal of Clinical Oncology · 2007 · 29 citations

Medicine, Oncology, Pharmacology +17